These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 28665159)
21. Fibromyalgia: should the treatment paradigm be monotherapy or combination pharmacotherapy? Mease PJ; Seymour K Curr Pain Headache Rep; 2008 Dec; 12(6):399-405. PubMed ID: 18973731 [TBL] [Abstract][Full Text] [Related]
22. Fibromyalgia is associated to receiving chronic medications beyond appropriateness: a cross-sectional study. Rivera J; Vallejo MA Rheumatol Int; 2016 Dec; 36(12):1691-1699. PubMed ID: 27664140 [TBL] [Abstract][Full Text] [Related]
23. Pregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports. Straube S; Derry S; Moore RA; McQuay HJ Rheumatology (Oxford); 2010 Apr; 49(4):706-15. PubMed ID: 20056767 [TBL] [Abstract][Full Text] [Related]
24. Duloxetine and pregabalin for pain management in multiple rheumatic diseases associated with fibromyalgia. Angeletti C; Guetti C; Piroli A; Angeletti PM; Paladini A; Ciccozzi A; Marinangeli F; Varrassi G Pain Pract; 2013 Nov; 13(8):657-62. PubMed ID: 23126475 [TBL] [Abstract][Full Text] [Related]
25. Pharmacological treatments of fibromyalgia: do complex conditions need complex therapies? Lawson K Drug Discov Today; 2008 Apr; 13(7-8):333-40. PubMed ID: 18405846 [TBL] [Abstract][Full Text] [Related]
26. Transient receptor potential vanilloid type 1 antagonists: a patent review (2011 - 2014). Lee Y; Hong S; Cui M; Sharma PK; Lee J; Choi S Expert Opin Ther Pat; 2015 Mar; 25(3):291-318. PubMed ID: 25666693 [TBL] [Abstract][Full Text] [Related]
27. Fibromyalgia: an update for oral health care providers. Balasubramaniam R; Laudenbach JM; Stoopler ET Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Nov; 104(5):589-602. PubMed ID: 17964475 [TBL] [Abstract][Full Text] [Related]
28. Novel antifungal agents: a patent review (2013 - present). Victoria Castelli M; Gabriel Derita M; Noelí López S Expert Opin Ther Pat; 2017 Apr; 27(4):415-426. PubMed ID: 27897041 [TBL] [Abstract][Full Text] [Related]
29. Long-term maintenance of response across multiple fibromyalgia symptom domains in a randomized withdrawal study of pregabalin. Pauer L; Atkinson G; Murphy TK; Petersel D; Zeiher B Clin J Pain; 2012 Sep; 28(7):609-14. PubMed ID: 22688598 [TBL] [Abstract][Full Text] [Related]
30. Prior Opioid Use Does Not Impact the Response to Pregabalin in Patients With Fibromyalgia. Argoff CE; Clair A; Emir B; Whalen E; Ortiz M; Pauer L Clin J Pain; 2016 Jul; 32(7):555-61. PubMed ID: 25756560 [TBL] [Abstract][Full Text] [Related]
31. Correlations between fibromyalgia symptom and function domains and patient global impression of change: a pooled analysis of three randomized, placebo-controlled trials of pregabalin. Arnold LM; Zlateva G; Sadosky A; Emir B; Whalen E Pain Med; 2011 Feb; 12(2):260-7. PubMed ID: 21266008 [TBL] [Abstract][Full Text] [Related]
32. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. Mease P J Rheumatol Suppl; 2005 Aug; 75():6-21. PubMed ID: 16078356 [TBL] [Abstract][Full Text] [Related]
33. Recent strategies for drug development in fibromyalgia syndrome. Blumenthal DE; Malemud CJ Expert Rev Neurother; 2016 Dec; 16(12):1407-1411. PubMed ID: 27362466 [TBL] [Abstract][Full Text] [Related]
34. Analgesic Effect of Electroacupuncture in a Mouse Fibromyalgia Model: Roles of TRPV1, TRPV4, and pERK. Lin JG; Hsieh CL; Lin YW PLoS One; 2015; 10(6):e0128037. PubMed ID: 26043006 [TBL] [Abstract][Full Text] [Related]
35. Challenges of implementing fibromyalgia treatment guidelines in current clinical practice. Arnold LM; Clauw DJ Postgrad Med; 2017 Sep; 129(7):709-714. PubMed ID: 28562155 [TBL] [Abstract][Full Text] [Related]
36. Pregabalin augmentation of quetiapine therapy in the treatment of fibromyalgia: an open-label, prospective trial. Calandre EP; Morillas-Arques P; Rodriguez-Lopez CM; Rico-Villademoros F; Hidalgo J Pharmacopsychiatry; 2007 Mar; 40(2):68-71. PubMed ID: 17447176 [TBL] [Abstract][Full Text] [Related]
37. The therapeutic potential of 5-HT1A receptors: a patent review. Lacivita E; Di Pilato P; De Giorgio P; Colabufo NA; Berardi F; Perrone R; Leopoldo M Expert Opin Ther Pat; 2012 Aug; 22(8):887-902. PubMed ID: 22788968 [TBL] [Abstract][Full Text] [Related]
39. The psychopharmacology of fibromyalgia: a drug development perspective. Kranzler JD; Gendreau JF; Rao SG Psychopharmacol Bull; 2002; 36(1):165-213. PubMed ID: 12397854 [TBL] [Abstract][Full Text] [Related]
40. A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain. Pergolizzi JV; Raffa RB; Taylor R; Rodriguez G; Nalamachu S; Langley P Pain Pract; 2013 Mar; 13(3):239-52. PubMed ID: 22716295 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]